Featured Post from Augusta University

Questions about shortages, the supply chain or the economy? Let Augusta’s experts help you find the answers

Jan 26, 2022

3 min

Richard Franza, PhD




Across America it seems deliveries are delayed; shelves are looking increasingly bare and there’s an elevated sense of anxiety when it comes to what lies ahead for America’s economy.




All of these important topics are forefront in the minds of many and reporters are covering these stories locally and nationally on a daily basis.


It's making news, and that’s why we’ve asked Dr. Richard M. Franza, the Dean of the James M. Hull College of Business at Augusta University, a few quick questions that we’re seeing pop up in media coverage across Georgia.




  • Q 1 - What is causing shortages here at home, especially in grocery stores?



“Like most things, it is complicated, not a lot of easy answers, but there are clearly a few things in play here. First, companies have been having a hard time finding workers throughout the supply chain. It starts at the producer level, whether it is meat processing plants or producers of other foods and sundry items, production levels are down due to limitations on workers. Then, there have also been worker issues at the transportation/logistics part of the supply chain. Particularly in the area of trucking. So, even when producers have enough supply, they are having difficulty getting it to the stores.


Finally, there are issues at the grocery stores themselves. Both at their distribution locations and the store themselves, they have been short on labor unloading and picking items, again delaying products from getting on the shelves. The problem has gotten worse in the past few weeks due to the COVID spikes due to omicron. While omicron is causing less serious results, it appears to be easier to catch. So, lots of people are getting it, making people have to miss work for five days, putting a further crunch on the labor force.”



  • Q 2 - Is this a problem we are likely to see continue through the first quarter or half of the year?


“I am optimistic that we can get past the omicron crunch in the coming weeks (by mid to late February, if not sooner). So, things should get better this quarter. However, this will just put us back to where we were pre-omicron, with still some lingering issues. I am hopeful that as the pandemic evolves into an endemic, things will resemble a more normal environment. While this virus has been unpredictable, I am hopeful that we can return to more normal environment no later than the end of the second quarter.”



  • Q 3 - What we can we expect once the pandemic finally subsides?


“I am extremely optimistic concerning our economy post-COVID. We have been pretty resilient to date, so I think if COVID transitions to endemic, I think we will see more spending and more people going to work.”




If you’ve got more questions to be answered, or if you’d like to speak with him one on one – then let us help.


Dr. Richard M. Franza is available to speak with media about important issues like America’s supply chain and the economy – simply click on his icon now to arrange an interview today.

Connect with:
Richard Franza, PhD

Richard Franza, PhD

Faculty, James M. Hull College of Business

Dr. Richard M. Franza is a professor and former dean of the James M. Hull College of Business.

ManagementOperations ResearchEntreprenuershipIntentional LeadershipHigher Education Leadership

You might also like...

Check out some other posts from Augusta University

2 min

Experts in the Media: CBD may help treat and reduce inflammation in Alzheimer's disease

In a recent Medical News Today article, Corrie Pelc reported on a study led by Babak Baban, PhD, in which inhaled CBD (cannabidiol) was tested in a mouse model of Alzheimer’s disease to examine its effects on neuroinflammation. Baban, associate dean for Research with AU's Dental College of Georgia and a professor with appointments in neurology and surgery in the Medical College of Georgia at Augusta University, explained that previous work from his group showed inhaled CBD to be more effective than oral or injected forms for certain neurological conditions, motivating them to explore its potential in Alzheimer’s research. He emphasized that Alzheimer’s is driven by multiple interacting biological processes – not just amyloid plaques – and sees inflammation as a promising new therapeutic target. In the study, inhaled CBD lowered activity in two major immune “alarm” pathways – IDO (indoleamine 2,3-dioxygenase) and cGAS-STING – both implicated in chronic inflammation. By dampening these pathways, CBD reduced levels of inflammatory cytokines and helped restore a more balanced immune environment in the brain. Baban framed this as a shift from symptom treatment to addressing underlying immune dysfunction, and noted that the findings could reorient how Alzheimer’s is approached. At the same time, he stressed that human trials are still needed: his team is preparing translational studies and holds an active Investigational New Drug (IND) application with the FDA for inhaled CBD in neuroinflammatory conditions, with Alzheimer’s disease as a natural next step. Read the full article here: Babak Baban, PhD, is a professor, immunologist and associate dean for research at the Dental College of Georgia at Augusta University where he has served for 13 of his 20 years as a translational and clinical immunologist. View his profile here Looking to know more about this important research or to connect with Babak Baban, PhD? He's available to speak with media – simply click on his icon to arrange an interview today.

3 min

Nursing researcher receives over $500K in prestigious grants

For the first time in nearly 15 years, a faculty member from Augusta University’s College of Nursing has been awarded a grant from the National Institutes of Health. Blake McGee, PhD, has secured an R03 award of $176,331 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development to study Medicaid’s expanded role in late postpartum maternal health. But he hasn’t stopped there as McGee is also part of the fifth cohort of Betty Irene Moore Fellows, a prestigious program for nurse leaders and innovators that has awarded CON half a million dollars to support his research project and leadership development. McGee, the prelicensure department chair and an associate professor, is collaborating with colleagues from other Georgia universities on both studies, which are occurring simultaneously. “I began my career as an ER nurse and have always wanted to ask bigger questions about the challenges facing patients and how we might best address them as a society,” said McGee, who was recently selected for publication in Blood Advances, the American Society of Hematology’s journal. “As nursing scientists, we are uniquely poised to ask questions about healthcare policy, specifically from the vantage point of the impact that policy choices have on patients and their health outcomes.” This century, the United States has seen rising maternal mortality rates with alarming racial disparities. Over half of these deaths occur in the postpartum period, with 23% occurring more than six weeks after delivery. Medicaid expansion covers pregnant women in households below 138% of the Federal poverty level through postpartum day 60, which has been associated with decreased mortality and reduced racial disparity in maternal death. At the time of grant submission, pregnancy Medicaid eligibility traditionally lapsed 60 days after delivery, leaving postpartum people vulnerable to disruptions in care. McGee’s work aims to identify changes in maternal health care use and health outcomes 60 days to 1 year after delivery that were associated with state Medicaid expansions (2007–19). The team will examine whether the effects of expansion vary by maternal race or ethnicity and will explore whether patient-reported health care access and quality mediate the relationships between expansion and outcomes. “My hope is that after the study we’ll have a better understanding of how health and health care use change for women in this crucial late postpartum period and how they may differ for people of different backgrounds,” said McGee. “Due to the sample design, findings will reliably inform optimal policy for postpartum coverage duration.” He expects this study to provide preliminary data for a future R01-funded study that directly examines the impact of extending the duration of postpartum Medicaid under the American Rescue Plan. As part of the Betty Irene Moore Fellowship, McGee is one of 15 fellows across the nation in a curriculum co-delivered by the UC Davis School of Nursing and Graduate School of Management. A project coordinator from AU’s School of Public Health will also assist with the fellowship project. McGee hopes to involve graduate research assistants or recent alumni as research associates on the team. Specifically, McGee will be studying the Georgia Pathways to Coverage Program, making him one of the only academic researchers in the nation funded to do so. “As a researcher, it is always a privilege to engage in topics that directly impact the current state of health care, and I’m honored to tackle projects that are so relevant to today’s health policy headlines,” he said. Georgia stands out among other states that are exploring an extension of Medicaid to low-income, working-age adults who demonstrate a monthly commitment of 80 hours to an employment-related activity. By studying the effects of this program, McGee predicts the findings will be highly relevant to anticipating the impact of recent Medicaid changes at the federal level and may indicate differences between Pathways participants and those who might qualify but remain uninsured. This focus could provide data that helps the state target enrollment efforts. The state’s own logic model predicts that the program will reduce hospitalizations, and McGee is eager to determine the program’s success. “Our findings should be helpful to the state to better understand those enrolling, what their experience with increased access to care has been and how their health has improved after receiving coverage,” McGee said.

1 min

#Expert Insights: Leaders share insights of Augusta University, Wellstar partnership at Health Connect South

In the two years since Augusta University and Wellstar Health System formally signed an agreement on August 30, 2023, the historic partnership has continued to evolve into a truly collaborative alliance. At its heart, the mission hasn’t changed: improving the health and wellbeing of all Georgians while educating and preparing the next generation of health care providers through access to world-class training. That was the message shared by Augusta University President Russell T. Keen, Medical College of Georgia at Augusta University Dean David C. Hess, MD, and former Wellstar President and CEO Candice L. Saunders at the recent Health Connect South conference held at the Georgia Aquarium in Atlanta. During their panel “Advancing Healthcare Through Public-Private Partnerships,” the three leaders – each instrumental in helping to create, implement and mold the historic partnership – shared with close to 1,100 attendees their insight into what makes the partnership beneficial for all and how it can be a model for advancing health care and health care education in Georgia and beyond. The full panel discussion is available for viewing here: It was an important event, and a full article is attached below as well. And if you're interested in learning more about the partnership between Augusta University and Wellstar, or connect with Augusta's President Russell T. Keen - simply click on his icon now to arrange an interview today.

View all posts
Powered by